成年人黄色毛片,四虎影在线永久免费四虎地址8848aa ,337p西西人体大胆瓣开下部,99久久99久久精品免观看,厨房里摸着乳丰满大屁股,视频一区二区欧美性爱

首頁 > 產(chǎn)品目錄 > 信號(hào)通路 > Cell Cycle | 細(xì)胞周期 > PERK > GSK2606414;GSK 2606414

GSK2606414;GSK 2606414

ChemLeader 98+%

GSK2606414;GSK 2606414

產(chǎn)品編號(hào):CL1098 CAS No.:1337531-36-8 MDLNo: 分子式:C24H20F3N5O 分子量:451.44
規(guī)格 庫(kù)存 目錄價(jià) 會(huì)員專享價(jià) 數(shù)量
20 mg In-stock ¥520.00 登錄后可見
- +
50 mg In-stock ¥850.00 登錄后可見
- +
100 mg In-stock ¥1450.00 登錄后可見
- +

化學(xué)品安全說明書(MSDS)

下載MSDS

質(zhì)檢證書(COA)

  • 基本信息
  • 相關(guān)文檔
  • 產(chǎn)品詳情
  • 相關(guān)文獻(xiàn)
基本信息
英文名稱 GSK2606414;GSK 2606414
中文名稱GSK2606414;GSK 2606414
CAS號(hào)1337531-36-8
分子式C24H20F3N5O
分子量451.44
外觀white powder
儲(chǔ)存條件 Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).
產(chǎn)品詳情

GSK2606414 is an orally available, selective protein kinase R-like ER kinase (PERK) inhibitor with an IC50 value of 0.4 nM. It can inhibit thapsigargin-induced PERK phosphorylation in lung carcinoma A549 cells and attenuates subcutaneous pancreatic human tumor xenograft growth in mice. Because PERK mediates the unfolded protein response pathway, which has roles in neurotoxicity and cancer, inhibition of PERK signaling has potential applications for the treatment of cancer and also cognitive degeneration.


相關(guān)文獻(xiàn)
抱歉,暫時(shí)沒有相關(guān)文獻(xiàn)
相關(guān)產(chǎn)品
抱歉,暫時(shí)沒有相關(guān)產(chǎn)品
在線客服
小德
021-58180488
小立
021-58180488
在線服務(wù)時(shí)間: 工作日 9:00-18:00